Science Explorer Back to mapMap
Discussion
Company · Ghent · Belgium

ActoGeniX (Belgium)

dna.comROR OpenAlex
Research works
11
fractional, all time
Citations
523
48.7 per fractional work
Top-10% rate
10.0%
all institutions 10.0%
Open access
45%
world 40%
International
36%
world 18%
ActoGeniX (Belgium)

Not ranked overall: ActoGeniX (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ActoGeniX (Belgium) work in?

In all years, 56% of research at ActoGeniX (Belgium) is in Life Sciences, 42% in Health Sciences. Its largest fields are Medicine (31%), Biochemistry, Genetics and Molecular Biology (31%), Immunology and Microbiology (11%). It does 1.9× the world's share of Life Sciences.

Life Sciences: 6 fractional works · 55.8% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 30.5% of its workGenetics: 2 fractional works · 14.0% of its workMolecular Biology: 1 fractional works · 12.8% of its workBiotechnology: 0 fractional works · 3.1% of its workEndocrinology: 0 fractional works · 0.7% of its workImmunology and Microbiology: 1 fractional works · 10.9% of its workImmunology: 1 fractional works · 10.2% of its workMicrobiology: 0 fractional works · 0.7% of its workAgricultural and Biological Sciences: 1 fractional works · 10.1% of its workFood Science: 1 fractional works · 10.1% of its workNeuroscience: 0 fractional works · 3.9% of its workCellular and Molecular Neuroscience: 0 fractional works · 3.9% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workHealth Sciences: 5 fractional works · 42.4% of its workMedicine: 3 fractional works · 30.7% of its workEpidemiology: 1 fractional works · 6.3% of its workSurgery: 1 fractional works · 6.1% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 5.2% of its workInfectious Diseases: 0 fractional works · 4.1% of its workPulmonary and Respiratory Medicine: 0 fractional works · 3.9% of its workOncology: 0 fractional works · 2.1% of its workGastroenterology: 0 fractional works · 1.0% of its workOtorhinolaryngology: 0 fractional works · 0.8% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.4% of its workNursing: 1 fractional works · 9.7% of its workNutrition and Dietetics: 1 fractional works · 9.7% of its workHealth Professions: 0 fractional works · 2.0% of its workEmergency Medical Services: 0 fractional works · 1.6% of its workPharmacy: 0 fractional works · 0.5% of its workPhysical Sciences: 0 fractional works · 1.9% of its workEngineering: 0 fractional works · 1.9% of its workBiomedical Engineering: 0 fractional works · 1.9% of its workALL ITS WORKActoGeniX(Belgium)11fractional works, all years
Life Sciences56%Physical Sciences2%Health Sciences42%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology330.5%
    2. Immunology and Microbiology110.9%
    3. Agricultural and Biological Sciences110.1%
    4. Neuroscience03.9%
    5. Pharmacology, Toxicology and Pharmaceutics00.4%
    1. Medicine330.7%
    2. Nursing19.7%
    3. Health Professions02.0%
    1. Engineering01.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from ActoGeniX (Belgium)?

The most cited paper from ActoGeniX (Belgium) is "Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis" (Klaas Vandenbroucke, Hans de Haard, Els Beirnaert et al., 2009), with 291 citations. Next come "Lactocepin Secreted By Lactobacillus Exerts Anti-Inflammatory Effects By Selectively Degrading Proinflammatory Chemokines" (240) and "Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice" (201).

Most cited papers
#PaperReleasedCitations
1 Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis Klaas Vandenbroucke, Hans de Haard, Els Beirnaert et al. · Mucosal Immunology Open access 30 Sep 2009 291
2 Lactocepin Secreted By Lactobacillus Exerts Anti-Inflammatory Effects By Selectively Degrading Proinflammatory Chemokines Marie‐Anne von Schillde, Gabriele Hörmannsperger, Monika Weiher et al. · Cell Host & Microbe Open access Apr 2012 240
3 Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice Tatiana Takiishi, Hannelie Korf, Tom L. Van Belle et al. · Journal of Clinical Investigation Open access 9 Apr 2012 201
4 Engineering lactococci and lactobacilli for human health Luis G. Bermúdez‐Humarán, Camille Aubry, Jean‐Paul Motta et al. · Current Opinion in Microbiology Review Jun 2013 166
5 Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives Anne Matthys, Guy Haegeman, Kathleen Van Craenenbroeck et al. · Molecular Neurobiology 21 Mar 2011 160
All 26 most cited papers, with filters and sorting

Which research topics does ActoGeniX (Belgium) publish most on?

By volume in 2022-now: Muscle activation and electromyography studies, Prosthetics and Rehabilitation Robotics and Mechanical Circulatory Support Devices.

Muscle activation and el…0Muscle activation and electromyography studies: 0 fractional worksProsthetics and Rehabili…0Prosthetics and Rehabilitation Robotics: 0 fractional worksMechanical Circulatory S…0Mechanical Circulatory Support Devices: 0 fractional works
Biomedical Engineering

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Muscle activation and electromyography studies Biomedical Engineering 0 works
  2. 2 Prosthetics and Rehabilitation Robotics Biomedical Engineering 0 works
  3. 3 Mechanical Circulatory Support Devices Biomedical Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.4%not open54.6%

World: 40% of research is openly available.

with international co-authors36.1%domestic only63.9%

World: 18% is written across borders.

How has ActoGeniX (Belgium)'s research output changed?

201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Ghent

All research institutions in Ghent

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ActoGeniX (Belgium). Posts are plain text and can be reported.